minor semantics but the value has increased through substantial steps in adding new platforms and through de-risking the portfolio through progressing trials.
The price has eroded - and this is really a function of the market struggling to price risk in the current climate for all biotech companies that are pre revenue.
I do t think you would get any new insight on the market pricing other than the ASX probably isn’t the right bourse for this stage of our journey.
minor semantics but the value has increased through substantial...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
-0.002(3.28%) |
Mkt cap ! $431.8M | |||
| Open | High | Low | Value | Volume |
| 6.2¢ | 6.4¢ | 5.9¢ | $919.2K | 15.26M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 899777 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 110472 | 3 |
View Market Depth
| Last trade - 16.10pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
5.9¢ |
Change
-0.002 ( 4.53 %) |
||||
| Open | High | Low | Volume | ||
| 6.2¢ | 6.4¢ | 5.9¢ | 5930301 | ||
| Last updated 15.58pm 06/06/2024 ? | |||||
| IMU (ASX) Chart |